Document is current
Any future updates will be listed below
-
Authors
Fortea, Adriana
van Eijndhoven, Philip
Calvet-Mirabent, Angels
Ilzarbe, Daniel
Batalla, Albert
de la Serna, Elena
Puig, Olga
Castro-Fornieles, Josefina
Dolz, Montserrat
Tor, Jordina
Parrilla, Sara
Via, Esther
Stephan-Otto, Christian
Baeza, Inmaculada
Sugranyes, Gisela
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI11/02684, PI11/1349, PI18/00976)
Fundación Alicia Koplowitz (2015, 2020)
Fundacio Clinic Recerca Biomedica (FCRB_PB1_2018)
- License Information
-
More Information
Article History
Received: 6 April 2023
Accepted: 3 August 2023
First Online: 29 August 2023
Declarations
:
: AF has received honoraria and travel support from Otsuka-Lundbeck, Janssen-Cilag and Rovi, and speaker fees from Abbott. DI has received continuing medical education support from Rubio and Angelini. MD has received travel support and honoraria from Otsuka-Lundbeck, Angelini, and Janssen. EV has received honoraria as sub-investigator in a Janssen-Cilag S.A. clinical trial. IB has received honoraria and travel support from Angelini, Otsuka-Lundbeck, and Janssen. GS has received speaker fees from Angelini. PvE, ACM, AB, ES, OP, JCF, JT, SP and CSO, declare no conflicts of interest.
